Mesa Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary

Mesa Laboratories

10/08/2026 22:02

Mesa Laboratories, Inc. MLAB.OQ reported quarterly adjusted earnings of 49 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 85 cents.  The mean expectation of three analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from -22 cents to 20 cents per share.
Revenue rose 1% to $60.14 million from a year ago; analysts expected $60.87 million. 
Mesa Laboratories, Inc.'s reported EPS for the quarter was 49 cents​.
The company reported quarterly net income of $2.83 million.
Mesa Laboratories, Inc. shares had risen by 3.1% this quarter and gained 30.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 113.6% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Mesa Laboratories, Inc. is $112.00, about 8.3% above its last closing price of $102.65
This summary was machine generated from LSEG data August 10 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.03
0.49
Beat
Mar. 31 2026 
0.34
-0.75
Missed
Dec. 31 2025 
0.28
0.65
Beat
Sep. 30 2025 
0.16
0.45
Beat